Nov 9 (Reuters) - Par Pharmaceutical Companies Inc:
* Announces extension and increase in maximum purchase price for 'modified
Dutch auction' tender offer to purchase up to $65,000,000 aggregate principal
amount of its currently outstanding 2.875% senior subordinated convertible
notes due
* Says price increased to not greater than $1,000.00 nor less than $982.50 per
$1,000 principal amount
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Announces extension and increase in maximum purchase price for 'modified
Dutch auction' tender offer to purchase up to $65,000,000 aggregate principal
amount of its currently outstanding 2.875% senior subordinated convertible
notes due
* Says price increased to not greater than $1,000.00 nor less than $982.50 per
$1,000 principal amount
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
